ESTIMATING THE COST-EFFECTIVENESS OF CELECOXIB FOR OSTEOARTHRITIS IN CHINA

被引：0
|
作者：
Wang, B. [1 ]
Xie, X. P. [2 ]
Furnback, W. [1 ]
Chen, C., I [2 ]
机构：
[1] Alliance Life Sci, Somerset, NJ USA
[2] Pfizer Inc, Beijing, Peoples R China
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.277
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS32
引用
收藏
页码：A46 / A46
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF IMRECOXIB, CELECOXIB AND DICLOFENAC IN OSTEOARTHRITIS IN CHINA
    Sun, X.
    Hu, X.
    Zhen, X.
    Li, Y.
    Gu, Y.
    Zhao, Z.
    Dong, H.
    [J]. VALUE IN HEALTH, 2020, 23 : S152 - S153
  • [2] Cost-effectiveness of lumiracoxib compared to celecoxib for the treatment of osteoarthritis in Canada
    Sambrook, J. C.
    Levy, A. R.
    Osenenko, K.
    Kindundu, C.
    Barbeau, M.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A117 - A118
  • [3] The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis.
    Maetzel, A
    Krahn, M
    Naglie, G
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S310 - S310
  • [4] The cost-effectiveness of celecoxib versus diclofenac in elderly patients with osteoarthritis of the hip or knees
    Jacobson, L
    Henriksson, F
    Ringertz, B
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 522 - 522
  • [5] COST-EFFECTIVENESS ANALYSIS OF CONTINUOUS VERSUS INTERMITTENT CELECOXIB USE FOR HIP AND KNEE OSTEOARTHRITIS
    Chopra, A. S.
    Gao, X.
    Liu, D.
    Ektare, V
    Dong, P.
    Shelbaya, A.
    Liu, Z.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A535 - A535
  • [6] COST-EFFECTIVENESS OF CHONDROITIN SULFATE PLUS GLUCOSAMINE VERSUS CELECOXIB FOR MODERATE TO SEVERE KNEE OSTEOARTHRITIS
    Eriakha, E.
    Siddiqua, C.
    Yang, Y.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S62 - S62
  • [7] ESTIMATING THE IMPACT OF EXPANDING ACCESS TO CELECOXIB FOR OSTEOARTHRITIS PATIENTS IN CHINA
    Wang, B. C. M.
    Xie, X. P.
    Furnback, W.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A772 - A772
  • [8] Estimating 'costs' for cost-effectiveness analysis
    Miners, Alec
    [J]. PHARMACOECONOMICS, 2008, 26 (09) : 745 - 751
  • [9] Estimating ‘Costs’ for Cost-Effectiveness Analysis
    Alec Miners
    [J]. PharmacoEconomics, 2008, 26 : 745 - 751
  • [10] Estimating cost-effectiveness of medical education
    Aitken, Gillian
    [J]. CLINICAL TEACHER, 2016, 13 (01): : 76 - 79
12345